Ładuje się......
Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types
BACKGROUND: PD(L)1 antibodies (anti‐PD(L)‐1) have been a major breakthrough in several types of cancer. Novel patterns of response and progression have been described with anti‐PD(L)‐1. We aimed at characterizing pseudoprogression (PSPD) among patients with various solid tumor types treated by anti‐...
Zapisane w:
| Wydane w: | Cancer Med |
|---|---|
| Główni autorzy: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7163099/ https://ncbi.nlm.nih.gov/pubmed/32074405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2797 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|